First Mercantile Trust’s Amphastar Pharmaceuticals AMPH Stock Holding History

First Mercantile Trust’s Portfolio AMPH Stock Details AMPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	$105K	Buy	+5,533	New	+$108K	0.01%	643

Other funds holding AMPH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

First Mercantile Trust's AMPH Position: Q3 2021 in Review

First Mercantile Trust opened a new position in Amphastar Pharmaceuticals (AMPH) in Q3 2021: 5,533 shares worth $105K. The stake represents 0.01% of the portfolio and ranks #643 among its holdings.

139 funds tracked by Wall St. Rank hold AMPH as of Q3 2021.

First Mercantile Trust held 5,533 shares of Amphastar Pharmaceuticals worth $105K as of Q3 2021.
Amphastar Pharmaceuticals was a new First Mercantile Trust position in Q3 2021.
Amphastar Pharmaceuticals made up 0.01% of First Mercantile Trust's portfolio in Q3 2021, its #643 holding.
139 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q3 2021.

Based on First Mercantile Trust's 13F filing for Q3 2021, filed 24 Nov 2021.